Higher consequence, lower reversibility, uncertainty, unfamiliar conditions, or weak support can warrant verification, escalation, or human review.
More defensible automation. More targeted human oversight.
When AI shapes care, coverage, claims, prior authorization, referrals, or access, the question is not simply how much work can be automated. It is whether the organization can explain what shaped the action, where human judgment entered, and why the case moved the way it did.
Chief AI, CIO, CTO, Data, Operations, Responsible AI, Governance, Risk, and Compliance.

Human oversight should be targeted, not absent and not automatic.
As AI moves into consequential healthcare workflows, blanket manual review can become its own bottleneck. The alternative is not less accountability. It is a control model that makes the cases requiring human judgment easier to identify, route, and explain.
Routine supported cases and exceptional cases should not automatically carry the same human-control burden.
Traceability and auditability matter when a case moves, stops, changes route, or requires meaningful human involvement.
Design. Build. Prove. Scale.
We work from the real clinical, payer, or operational workflow, not from a generic governance checklist. Decision control can span the lifecycle where the workflow requires it.
Define the operating model.
Clarify the consequential decision, human authority, evidence, policy, escalation path, and operating boundaries before the workflow scales.
Build in the real environment.
Develop or improve AI applications, agentic workflows, integrations, workflow logic, and the operating controls required for regulated use.
Test whether it works.
Measure the clinical, operational, adoption, and economic evidence needed to justify broader use.
Expand with the right control model.
Move validated AI into broader operations while keeping human authority and oversight proportional to the workflow.
When AI influences consequential actions and the workflow needs persistent decision-level control, DCP is designed to return a handling response such as proceed, verify, review, hold, or escalate under the organization's approved control model. It does not replace the clinician, payer, agency, or business owner and does not approve or deny anything on its own.
The healthcare work is grounded in clinical AI and enterprise data science experience.
These are founder experience signals, not GNS-AI client outcome claims.
Clinical AI product work
Built an oncology triage chatbot and recommender aligned to ASCO clinical guidance and developed with clinical experts.
Ph.D. Biomedical Engineering
Research focused on adaptive systems, boundaries, uncertainty, and how performance changes near operating limits.
Abbott Diagnostics
Enterprise healthcare data science experience spanning laboratory analytics, automation, benchmarking, and machine learning infrastructure.
For the federal prior-authorization interoperability context, see the CMS Interoperability and Prior Authorization Final Rule (CMS-0057-F). The site links the primary source rather than summarizing legal requirements.
Have one healthcare or payer workflow where AI authority is either too constrained or too broad?
Bring it to a fit call. We will determine whether the next step is Review, direct Build, a Decision Control Assessment, or no engagement.
